BRETEC — Bioretec Oy Share News
0.000.00%
Last trade - 00:00- €30.86m
- €27.17m
- €3.52m
Brief: Change Negotiations Completed At Bioretec
Brief: Bioretec: Change Negotiations Completed
Brief: Bioretec 9M EBITDA EUR -6.325 Million
Brief: Bioretec Starts Change Negotiations
Brief: Bioretec Adjusts And Restates Previously Reported Net Sales For H1/2025 And Does Not Expect Accelerated Sales In 2025
Brief: Bioretec Withdraws Financial Targets
Brief: Bioretec's RemeOs™ Screw Receives Medicare Payment Approval in US
Brief: Bioretec's Remeos Screw Lag Solid Gets CMS TPT In The US
Brief: Anne-Mari Matikainen Appointed As Interim CFO Of Bioretec
Brief: Bioretec Extends Timeline For DrillPin Commercialization In 2025
Brief: Bioretec Appoints Dr. Christopher W. Digiovanni To Scientific Advisory Board
Brief: Bioretec Appoints Sarah Van Hellenberg Hubar-Fisher As CEO
Brief: Bioretec Appoints Sarah Van Hellenberg Hubar-Fisher As Chief Executive Officer
Brief: Bioretec H1 EBITDA EUR -3.73 Million
Brief: Bioretec Announces Preliminary Result Of Rights Issue
Brief: Bioretec Resolves On Rights Issue Of About EUR 9.2 Mln
Brief: Bioretec Appoints Sarah Van Hellenberg Hubar-Fisher Interim CEO
Brief: BIORETEC says CEO Alan Donze To Resign Effective July 7, 2025
Brief: Bioretec's CEO Alan Donze To Resign